Suivre
T. H. Jones
T. H. Jones
Autres nomsT. Hugh Jones, Thomas Hugh Jones, H. Jones
Hon. Professor of Andrology Sheffield University
Adresse e-mail validée de sheffield.ac.uk
Titre
Citée par
Citée par
Année
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
D Kapoor, E Goodwin, KS Channer, TH Jones
European journal of endocrinology 154 (6), 899-906, 2006
10292006
The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men
CJ Malkin, PJ Pugh, RD Jones, D Kapoor, KS Channer, TH Jones
The Journal of Clinical Endocrinology & Metabolism 89 (7), 3313-3318, 2004
9132004
Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study
KM English, RP Steeds, TH Jones, MJ Diver, KS Channer
Circulation 102 (16), 1906-1911, 2000
7652000
Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)
TH Jones, S Arver, HM Behre, J Buvat, E Meuleman, I Moncada, ...
Diabetes care 34 (4), 828-837, 2011
7052011
Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity
D Kapoor, H Aldred, S Clark, KS Channer, TH Jones
Diabetes care 30 (4), 911-917, 2007
6812007
Testosterone: a metabolic hormone in health and disease
DM Kelly, TH Jones
Journal of Endocrinology 217 (3), R25-R45, 2013
6632013
European Association of Urology guidelines on sexual and reproductive health—2021 update: male sexual dysfunction
A Salonia, C Bettocchi, L Boeri, P Capogrosso, J Carvalho, NC Cilesiz, ...
European urology 80 (3), 333-357, 2021
5832021
Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms
KM English, O Mandour, RP Steeds, MJ Diver, TH Jones, KS Channer
European heart journal 21 (11), 890-894, 2000
5722000
Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial
CJ Malkin, PJ Pugh, JN West, EJR van Beek, TH Jones, KS Channer
European heart journal 27 (1), 57-64, 2006
5272006
Testosterone and obesity
DM Kelly, TH Jones
Obesity Reviews 16 (7), 581-606, 2015
5162015
Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes
V Muraleedharan, H Marsh, D Kapoor, KS Channer, TH Jones
European journal of endocrinology 169 (6), 725-733, 2013
4922013
Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes
C Wang, G Jackson, TH Jones, AM Matsumoto, A Nehra, MA Perelman, ...
Diabetes care 34 (7), 1669-1675, 2011
4672011
Androgens, insulin resistance and vascular disease in men
D Kapoor, CJ Malkin, KS Channer, TH Jones
Clinical endocrinology 63 (3), 239-250, 2005
4532005
European association of urology guidelines on male sexual and reproductive health: 2021 update on male infertility
S Minhas, C Bettocchi, L Boeri, P Capogrosso, J Carvalho, NC Cilesiz, ...
European urology 80 (5), 603-620, 2021
4382021
Smoking and hormones in health and endocrine disorders
D Kapoor, TH Jones
European journal of endocrinology 152 (4), 491-499, 2005
4262005
Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life
CJ Malkin, PJ Pugh, PD Morris, KE Kerry, RD Jones, TH Jones, ...
Heart 90 (8), 871-876, 2004
3702004
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
PM Rao, DM Kelly, TH Jones
Nature Reviews Endocrinology 9 (8), 479-493, 2013
3602013
Testosterone: a vascular hormone in health and disease
DM Kelly, TH Jones
Journal of Endocrinology 217 (3), R47-R71, 2013
3472013
Low serum testosterone and increased mortality in men with coronary heart disease
CJ Malkin, PJ Pugh, PD Morris, S Asif, TH Jones, KS Channer
Heart 96 (22), 1821-1825, 2010
3462010
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
WT Garvey, JP Frias, AM Jastreboff, CW le Roux, N Sattar, D Aizenberg, ...
The Lancet 402 (10402), 613-626, 2023
3262023
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20